English
metomidate
Sign in to saveMetomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965 and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.
Research
181 papers- (11)C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature.Endocrine · 2020
- [(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial.Nature medicine · 2023
- Metomidate-based imaging of adrenal masses.Hormones & cancer · 2011
- Lateralization in (11) C-Metomidate PET and outcome of adrenalectomy in primary aldosteronism.Endocrinology, diabetes & metabolism · 2022
- The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review.CNS drugs · 2025
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Metomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965 and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.
11C-labelled metomidate (11C-metomidate), may be used with positron emission tomography (PET). For instance, to detect tumors of adrenocortical origin.
Excerpted from Wikipedia’s “metomidate” article, available under the CC BY-SA 4.0 licence.